These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 3044892)
1. Interrelationships among insulin's antilipolytic and glucoregulatory effects and plasma triglycerides in nondiabetic and diabetic patients with endogenous hypertriglyceridemia. Yki-Järvinen H; Taskinen MR Diabetes; 1988 Sep; 37(9):1271-8. PubMed ID: 3044892 [TBL] [Abstract][Full Text] [Related]
2. Sex differences in African-Americans regarding sensitivity to insulin's glucoregulatory and antilipolytic actions. Sumner AE; Kushner H; Sherif KD; Tulenko TN; Falkner B; Marsh JB Diabetes Care; 1999 Jan; 22(1):71-7. PubMed ID: 10333906 [TBL] [Abstract][Full Text] [Related]
3. Decreasing triglyceride by gemfibrozil therapy does not affect the glucoregulatory or antilipolytic effect of insulin in nondiabetic subjects with mild hypertriglyceridemia. Sane T; Knudsen P; Vuorinen-Markkola H; Yki-Järvinen H; Taskinen MR Metabolism; 1995 May; 44(5):589-96. PubMed ID: 7752906 [TBL] [Abstract][Full Text] [Related]
4. Chronic physiologic hyperinsulinemia impairs suppression of plasma free fatty acids and increases de novo lipogenesis but does not cause dyslipidemia in conscious normal rats. Koopmans SJ; Kushwaha RS; DeFronzo RA Metabolism; 1999 Mar; 48(3):330-7. PubMed ID: 10094109 [TBL] [Abstract][Full Text] [Related]
5. The antilipolytic action of insulin in obese subjects with resistance to its glucoregulatory action. Howard BV; Klimes I; Vasquez B; Brady D; Nagulesparan M; Unger RH J Clin Endocrinol Metab; 1984 Mar; 58(3):544-8. PubMed ID: 6363441 [TBL] [Abstract][Full Text] [Related]
7. Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects. Halberstam M; Cohen N; Shlimovich P; Rossetti L; Shamoon H Diabetes; 1996 May; 45(5):659-66. PubMed ID: 8621019 [TBL] [Abstract][Full Text] [Related]
8. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia. Julius U Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628 [TBL] [Abstract][Full Text] [Related]
9. Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans. European Group for the Study of Insulin Resistance (EGIR). Baldeweg SE; Golay A; Natali A; Balkau B; Del Prato S; Coppack SW Eur J Clin Invest; 2000 Jan; 30(1):45-52. PubMed ID: 10620001 [TBL] [Abstract][Full Text] [Related]
10. Relation of plasma lipids to insulin resistance, nonesterified fatty acid levels, and body fat in men from three ethnic groups: relevance to variation in risk of diabetes and coronary disease. Zoratti R; Godsland IF; Chaturvedi N; Crook D; Crook D; Stevenson JC; McKeigue PM Metabolism; 2000 Feb; 49(2):245-52. PubMed ID: 10690953 [TBL] [Abstract][Full Text] [Related]
11. Continuous 24-h nicotinic acid infusion in rats causes FFA rebound and insulin resistance by altering gene expression and basal lipolysis in adipose tissue. Oh YT; Oh KS; Choi YM; Jokiaho A; Donovan C; Choi S; Kang I; Youn JH Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1012-21. PubMed ID: 21386057 [TBL] [Abstract][Full Text] [Related]
12. Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability. Oakes ND; Thalén PG; Jacinto SM; Ljung B Diabetes; 2001 May; 50(5):1158-65. PubMed ID: 11334421 [TBL] [Abstract][Full Text] [Related]
13. Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia. Rivellese AA; Maffettone A; Iovine C; Di Marino L; Annuzzi G; Mancini M; Riccardi G Diabetes Care; 1996 Nov; 19(11):1207-13. PubMed ID: 8908381 [TBL] [Abstract][Full Text] [Related]
14. On the suppression of plasma nonesterified fatty acids by insulin during enhanced intravascular lipolysis in humans. Carpentier AC; Frisch F; Cyr D; Généreux P; Patterson BW; Giguère R; Baillargeon JP Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E849-56. PubMed ID: 15972273 [TBL] [Abstract][Full Text] [Related]
15. Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin dependent diabetes by glucose tolerance test criteria. Hollenbeck CB; Johnston P; Varasteh BB; Chen YD; Reaven GM Diabete Metab; 1991; 17(5):483-9. PubMed ID: 1752350 [TBL] [Abstract][Full Text] [Related]
16. The glucoregulatory and antilipolytic actions of insulin in abdominal obesity with normal or impaired glucose tolerance: an in vivo and in vitro study. Cavallo-Perin P; Bruno A; Cassader M; Cesco L; Gruden G; Pagano G Eur J Clin Invest; 1992 Nov; 22(11):725-31. PubMed ID: 1478241 [TBL] [Abstract][Full Text] [Related]
17. Sensitivity to acute insulin-mediated suppression of plasma free fatty acids is not a determinant of fasting VLDL triglyceride secretion in healthy humans. Carpentier A; Patterson BW; Leung N; Lewis GF Diabetes; 2002 Jun; 51(6):1867-75. PubMed ID: 12031975 [TBL] [Abstract][Full Text] [Related]
18. Short-term administration of isotretinoin elevates plasma triglyceride concentrations without affecting insulin sensitivity in healthy humans. Stoll D; Binnert C; Mooser V; Tappy L Metabolism; 2004 Jan; 53(1):4-10. PubMed ID: 14681834 [TBL] [Abstract][Full Text] [Related]
19. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. Rebrin K; Steil GM; Mittelman SD; Bergman RN J Clin Invest; 1996 Aug; 98(3):741-9. PubMed ID: 8698866 [TBL] [Abstract][Full Text] [Related]
20. Further evidence for a central role of adipose tissue in the antihyperglycemic effect of metformin. Abbasi F; Carantoni M; Chen YD; Reaven GM Diabetes Care; 1998 Aug; 21(8):1301-5. PubMed ID: 9702437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]